Hcw Biologics Inc (HCWB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HCWB Annual Balance Sheets →
The table below presents a historical view of Hcw Biologics Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.74
Cash & Short-term Investments0.00
Accounts receivable0.02
Other Current Assets0.00
Prepaid Expense, Current AS0.28
Total Current Assets1.14
Equipment/Property/Plant Net20.75
Long-term investments4.85
Other Assets, Noncurrent0.03
Total Assets26.77
Liabilities
Accounts Payable, Current AC0.12
Accrued Liabilities And Other Liabilities1.72
Short-term Debt DE16.56
Other Liabilities, Current9.90
Deferred Revenue, Current DE0.35
Total Current Liabilities18.65
Long-term debt0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent0.69
Total Liabilities19.34
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock117.69
Retained Earnings / Accumulated Deficit-110.26
Other Equity0.00
Common Stockholder's Equity7.43
Total Stockholder's Equity7.43
Liabilities & Stockholder's Equity26.77
4 historic quarters locked

Sign in to unlock the full Hcw Biologics Inc balance sheet history.

About Hcw Biologics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-038262

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.